The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.

Hundreds of vials of black-market weight loss drugs have been seized from a home and two clinics in West Tennessee.

Fact checked by Nick Blackmer Eli Lilly’s Zepbound bested Novo Nordisk’s Wegovy in the first head-to-head trial comparing ...

The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of GLP-1 weight-loss ...

Tirzepatide treatment led to a 47% greater relative reduction in weight compared with semaglutide. Topline results were announced from a phase 3b clinical trial comparing tirzepatide with ...

Grazing between meals? Can’t watch TV without something to munch on? Reaching for a midnight snack, night after night? If ...

A recent New York Times story described a new fad: "microdosing" GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) ...

The European Medicines Agency has allowed Eli Lilly to update the product label of its weight-loss drug Mounjaro to show it ...

Stock Editorial via Getty Images An expert panel of the EU drug regulator, the European Medicines Agency (EMA), has ...

Treatment with GLP-1RAs was associated with significant improvements in obstructive sleep apnea-related health outcomes.

People struggling with their body weight experienced joy when new, more effective prescription drug options became the rage ...

Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?